155 related articles for article (PubMed ID: 27659347)
1. Comparative analysis of gene expression profiles of OPN signaling pathway in four kinds of liver diseases.
Wang G; Chen S; Zhao C; Li X; Zhao W; Yang J; Chang C; Xu C
J Genet; 2016 Sep; 95(3):741-50. PubMed ID: 27659347
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles predict the possible regulatory role of OPN-mediated signaling pathways in rat liver regeneration.
Wang G; Chen S; Zhao C; Li X; Zhang L; Zhao W; Chang C; Xu C
Gene; 2016 Feb; 576(2 Pt 2):782-90. PubMed ID: 26581507
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of gene expression profiles of acute hepatic failure and that of liver regeneration in rat.
Xu C; Zhao W; Hao Y; Chang C; Fan J
Gene; 2013 Oct; 528(2):59-66. PubMed ID: 23916745
[TBL] [Abstract][Full Text] [Related]
4. Comparative Analysis of Expression Profiles of Reg Signaling Pathways-Related Genes Between AHF and HCC.
Wang G; Cheng L; Chen M; Zhao C; Gao M; Huang T; Chu P; Xu C
Biochem Genet; 2019 Jun; 57(3):382-402. PubMed ID: 30600408
[TBL] [Abstract][Full Text] [Related]
5. Expression profiles uncover the correlation of OPN signaling pathways with rat liver regeneration at cellular level.
Wang G; Li X; Chen S; Zhao W; Yang J; Chang C; Xu C
Cell Biol Int; 2015 Nov; 39(11):1329-40. PubMed ID: 26269331
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin Takes Center Stage in Chronic Liver Disease.
Song Z; Chen W; Athavale D; Ge X; Desert R; Das S; Han H; Nieto N
Hepatology; 2021 Apr; 73(4):1594-1608. PubMed ID: 32986864
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the expression profiles of genes related to the Gadd45α signaling pathway in four kinds of liver diseases.
Yang X; Chen X; Xia C; Li S; Zhu L; Xu C
Histol Histopathol; 2020 Sep; 35(9):949-960. PubMed ID: 32298459
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease.
Shen X; Guo H; Xu J; Wang J
J Cell Physiol; 2019 Aug; 234(10):18169-18179. PubMed ID: 30908654
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the role of JNK signaling pathway in regulating cell proliferation and apoptosis of rat liver regeneration and rat acute hepatic failure.
Xu C; Zhi J; Zhao W; Zhang L; Li D
Genetika; 2012 Aug; 48(8):909-17. PubMed ID: 23035542
[TBL] [Abstract][Full Text] [Related]
10. The hedgehog pathway in nonalcoholic fatty liver disease.
Verdelho Machado M; Diehl AM
Crit Rev Biochem Mol Biol; 2018 Jun; 53(3):264-278. PubMed ID: 29557675
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiles reveal significant differences between rat liver cancer and liver regeneration.
Wang G; Xu C; Zhi J; Hao Y; Zhang L; Chang C
Gene; 2012 Aug; 504(1):41-52. PubMed ID: 22575612
[TBL] [Abstract][Full Text] [Related]
12. Characterization of transcriptional modules related to fibrosing-NAFLD progression.
Lou Y; Tian GY; Song Y; Liu YL; Chen YD; Shi JP; Yang J
Sci Rep; 2017 Jul; 7(1):4748. PubMed ID: 28684781
[TBL] [Abstract][Full Text] [Related]
13. Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes.
Liu XL; Ming YN; Zhang JY; Chen XY; Zeng MD; Mao YM
Exp Mol Med; 2017 Jan; 49(1):e283. PubMed ID: 28082742
[TBL] [Abstract][Full Text] [Related]
14. Correlation analysis between gene expression profile of high-fat emulsion-induced non-alcoholic fatty liver and liver regeneration in rat.
Wang G; Li B; Hao Y; Zhi J; He C; Xu C
Cell Biol Int; 2013 Sep; 37(9):917-28. PubMed ID: 23619824
[TBL] [Abstract][Full Text] [Related]
15. Integrative transcriptomic analysis of NAFLD animal model reveals dysregulated genes and pathways in metabolism.
Yang W; He Y; Liu S; Gan L; Zhang Z; Wang J; Liang J; Dong Y; Wang Q; Hou Z; Yang L
Gene; 2016 Dec; 595(1):99-108. PubMed ID: 27697615
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially methylated region (DMR) networks associated with progression of nonalcoholic fatty liver disease.
Hotta K; Kitamoto A; Kitamoto T; Ogawa Y; Honda Y; Kessoku T; Yoneda M; Imajo K; Tomeno W; Saito S; Nakajima A
Sci Rep; 2018 Sep; 8(1):13567. PubMed ID: 30206277
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin - A potential biomarker of advanced liver disease.
Bruha R; Vitek L; Smid V
Ann Hepatol; 2020; 19(4):344-352. PubMed ID: 32005637
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J
Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147
[TBL] [Abstract][Full Text] [Related]
19. Hepatic transcriptome signatures in mice and humans with nonalcoholic fatty liver disease.
Ding Y; Dai X; Bao M; Xing Y; Liu J; Zhao S; Liu E; Yuan Z; Bai L
Animal Model Exp Med; 2023 Aug; 6(4):317-328. PubMed ID: 37565549
[TBL] [Abstract][Full Text] [Related]
20. Role of Osteopontin in Liver Diseases.
Wen Y; Jeong S; Xia Q; Kong X
Int J Biol Sci; 2016; 12(9):1121-8. PubMed ID: 27570486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
